These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 37459272)
1. Cancer Cell Membrane Wrapped Nanoparticles for the Delivery of a Bcl-2 Inhibitor to Triple-Negative Breast Cancer. Scully MA; Wilkins DE; Dang MN; Hoover EC; Aboeleneen SB; Day ES Mol Pharm; 2023 Aug; 20(8):3895-3913. PubMed ID: 37459272 [TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer. Valcourt DM; Dang MN; Scully MA; Day ES ACS Nano; 2020 Mar; 14(3):3378-3388. PubMed ID: 32083466 [TBL] [Abstract][Full Text] [Related]
3. Membrane-Cloaked Nanoparticles for RNA Interference of β-Catenin in Triple-Negative Breast Cancer. Scully MA; Wilhelm R; Wilkins DE; Day ES ACS Biomater Sci Eng; 2024 Mar; 10(3):1355-1363. PubMed ID: 38306303 [TBL] [Abstract][Full Text] [Related]
4. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer. Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759 [TBL] [Abstract][Full Text] [Related]
5. Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer. Niu M; Valdes S; Naguib YW; Hursting SD; Cui Z Mol Pharm; 2016 Jun; 13(6):1833-42. PubMed ID: 27074028 [TBL] [Abstract][Full Text] [Related]
6. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition. Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637 [TBL] [Abstract][Full Text] [Related]
7. Glutathione Programmed Mitochondria Targeted Delivery of Lonidamine for Effective Against Triple Negative Breast Cancer. Wang Z; Qin Y; Wang X; Zhang T; Hu Y; Wang D; Zhang L; Zhu Y Int J Nanomedicine; 2023; 18():4023-4042. PubMed ID: 37520302 [TBL] [Abstract][Full Text] [Related]
8. Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells. Bressler EM; Kim J; Shmueli RB; Mirando AC; Bazzazi H; Lee E; Popel AS; Pandey NB; Green JJ J Biomed Mater Res A; 2018 Jun; 106(6):1753-1764. PubMed ID: 29424479 [TBL] [Abstract][Full Text] [Related]
9. Lipase-triggered drug release from BCL2 inhibitor ABT-199-loaded nanoparticles to elevate anti-leukemic activity through enhanced drug targeting on the mitochondrial membrane. Liang B; Jiang D; Pan L; Xiong F; Feng S; Wu S; Ye H; Yu Z; Shi C; Gao S Acta Biomater; 2022 Jun; 145():246-259. PubMed ID: 35405327 [TBL] [Abstract][Full Text] [Related]
10. Delivery of novel coumarin-dihydropyrimidinone conjugates through mixed polymeric nanoparticles to potentiate therapeutic efficacy against triple-negative breast cancer. Ghosh A; Upadhyay P; Sarker S; Das S; Bhattacharjee M; Bhattacharya S; Ahir M; Guria S; Gupta P; Chattopadhyay S; Ghosh S; Adhikari S; Adhikary A Biomater Sci; 2021 Aug; 9(16):5665-5690. PubMed ID: 34259681 [TBL] [Abstract][Full Text] [Related]
11. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid). Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340 [TBL] [Abstract][Full Text] [Related]
12. Olaparib@human serum albumin nanoparticles as sustained drug-releasing tumour-targeting nanomedicine to inhibit growth and metastasis in the mouse model of triple-negative breast cancer. Vysyaraju NR; Paul M; Ch S; Ghosh B; Biswas S J Drug Target; 2022 Dec; 30(10):1088-1105. PubMed ID: 35723068 [TBL] [Abstract][Full Text] [Related]
13. Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy. Gong C; Yu X; You B; Wu Y; Wang R; Han L; Wang Y; Gao S; Yuan Y J Nanobiotechnology; 2020 Jun; 18(1):92. PubMed ID: 32546174 [TBL] [Abstract][Full Text] [Related]
14. Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitors in triple-negative breast cancer cell line. Byrne CE; Astete CE; Vaithiyanathan M; Melvin AT; Moradipour M; Rankin SE; Knutson BL; Sabliov CM; Martin EC Nanomedicine (Lond); 2020 Apr; 15(10):981-1000. PubMed ID: 32238059 [No Abstract] [Full Text] [Related]
15. Synthesis, characterization, and evaluation of in vitro cytotoxicity and in vivo antitumor activity of asiatic acid-loaded poly lactic-co-glycolic acid nanoparticles: A strategy of treating breast cancer. Dutta S; Chakraborty P; Basak S; Ghosh S; Ghosh N; Chatterjee S; Dewanjee S; Sil PC Life Sci; 2022 Oct; 307():120876. PubMed ID: 35961595 [TBL] [Abstract][Full Text] [Related]
16. Orlistat and antisense-miRNA-loaded PLGA-PEG nanoparticles for enhanced triple negative breast cancer therapy. Bhargava-Shah A; Foygel K; Devulapally R; Paulmurugan R Nanomedicine (Lond); 2016 Feb; 11(3):235-47. PubMed ID: 26787319 [TBL] [Abstract][Full Text] [Related]
17. Ultrasound-guided delivery of thymidine kinase-nitroreductase dual therapeutic genes by PEGylated-PLGA/PIE nanoparticles for enhanced triple negative breast cancer therapy. Devulapally R; Lee T; Barghava-Shah A; Sekar TV; Foygel K; Bachawal SV; Willmann JK; Paulmurugan R Nanomedicine (Lond); 2018 May; 13(9):1051-1066. PubMed ID: 29790803 [TBL] [Abstract][Full Text] [Related]
18. Homologous-targeting biomimetic nanoparticles co-loaded with melittin and a photosensitizer for the combination therapy of triple negative breast cancer. Zhang T; Bai L; You R; Yang M; Chen Q; Cheng Y; Qian Z; Wang Y; Liu Y J Mater Chem B; 2024 Jun; 12(22):5465-5478. PubMed ID: 38742364 [TBL] [Abstract][Full Text] [Related]
19. PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway. Bao W; Liu R; Wang Y; Wang F; Xia G; Zhang H; Li X; Yin H; Chen B Int J Nanomedicine; 2015; 10():557-66. PubMed ID: 25609961 [TBL] [Abstract][Full Text] [Related]
20. Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy. He W; Li X; Morsch M; Ismail M; Liu Y; Rehman FU; Zhang D; Wang Y; Zheng M; Chung R; Zou Y; Shi B ACS Nano; 2022 Apr; 16(4):6293-6308. PubMed ID: 35353498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]